• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用临床肺功能测定数据估计肺功能变化率。

Estimating rate of lung function change using clinical spirometry data.

机构信息

Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA

Asymmetric Operations Sector, Johns Hopkins University Applied Physics Laboratory, Laurel, Maryland, USA.

出版信息

BMJ Open Respir Res. 2024 Oct 3;11(1):e001896. doi: 10.1136/bmjresp-2023-001896.

DOI:10.1136/bmjresp-2023-001896
PMID:39362797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11459324/
Abstract

RATIONALE

In chronic obstructive pulmonary disease (COPD), accurately estimating lung function from electronic health record (EHR) data would be beneficial but requires addressing complexities in clinically obtained testing. This study compared analytic methods for estimating rate of forced expiratory volume in one second (FEV) change from EHR data.

METHODS

We estimated rate of FEV change in patients with COPD from a single centre who had ≥3 outpatient tests spanning at least 1 year. Estimates were calculated as both an absolute mL/year and a relative %/year using non-regressive (Total Change, Average Change) and regressive (Quantile, RANSAC, Huber) methods. We compared distributions of the estimates across methods focusing on extreme values. Univariate zero-inflated negative binomial regressions tested associations between estimates and all-cause or COPD hospitalisations. Results were validated in an external cohort.

RESULTS

Among 1417 participants, median rate of change was approximately -30 mL/year or -2%/year. Non-regressive methods frequently generated erroneous estimates due to outlier first measurements or short intervals between tests. Average change yielded the most extreme estimates (minimum=-3761 mL/year), while regressive methods, and Huber specifically, minimised extreme estimates. Huber, Total Change and Quantile FEV slope estimates were associated with all-cause hospitalisations (Huber incidence rate ratio 0.98, 95% CI 0.97 to 0.99, p<0.001). Huber estimates were also associated with smoking status, comorbidities and prior hospitalisations. Similar results were identified in an external validation cohort.

CONCLUSIONS

Using EHR data to estimate FEV rate of change is clinically applicable but sensitive to challenges intrinsic to clinically obtained data. While no analytic method will fully overcome these complexities, we identified Huber regression as useful in defining an individual's lung function change using EHR data.

摘要

背景

在慢性阻塞性肺疾病(COPD)中,从电子健康记录(EHR)数据中准确估计肺功能将是有益的,但需要解决临床获得的测试中的复杂性。本研究比较了从至少有 3 次门诊测试、时间跨度至少 1 年的 COPD 患者的 EHR 数据中估计 1 秒用力呼气量(FEV)变化率的分析方法。

方法

我们从一个单一的中心估计了 COPD 患者的 FEV 变化率,这些患者至少有 3 次门诊测试,时间跨度至少为 1 年。使用非回归(总变化、平均变化)和回归(分位数、RANsac、Huber)方法,将估计值分别计算为 mL/年的绝对值和 %/年的相对值。我们比较了不同方法的估计值的分布,重点是极端值。单变量零膨胀负二项回归检验了估计值与全因或 COPD 住院之间的关系。结果在外部队列中得到了验证。

结果

在 1417 名参与者中,变化率的中位数约为-30mL/年或-2%/年。非回归方法由于第一个测量值的异常值或测试之间的间隔较短,经常产生错误的估计值。平均变化产生了最极端的估计值(最小值=-3761mL/年),而回归方法,特别是 Huber,最小化了极端估计值。Huber、总变化和分位数 FEV 斜率估计值与全因住院有关(Huber 发病率比 0.98,95%CI 0.97 至 0.99,p<0.001)。Huber 估计值也与吸烟状况、合并症和既往住院有关。在外部验证队列中也发现了类似的结果。

结论

使用 EHR 数据估计 FEV 变化率在临床上是可行的,但对临床获得的数据中的固有挑战很敏感。虽然没有任何分析方法能够完全克服这些复杂性,但我们发现 Huber 回归在使用 EHR 数据定义个体的肺功能变化方面是有用的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/11459324/211c6b492681/bmjresp-11-1-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/11459324/993c05d52807/bmjresp-11-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/11459324/9eda48a0435a/bmjresp-11-1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/11459324/335989163347/bmjresp-11-1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/11459324/80f05b179e9f/bmjresp-11-1-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/11459324/211c6b492681/bmjresp-11-1-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/11459324/993c05d52807/bmjresp-11-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/11459324/9eda48a0435a/bmjresp-11-1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/11459324/335989163347/bmjresp-11-1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/11459324/80f05b179e9f/bmjresp-11-1-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62a0/11459324/211c6b492681/bmjresp-11-1-g005.jpg

相似文献

1
Estimating rate of lung function change using clinical spirometry data.使用临床肺功能测定数据估计肺功能变化率。
BMJ Open Respir Res. 2024 Oct 3;11(1):e001896. doi: 10.1136/bmjresp-2023-001896.
2
Relationships between symptoms and lung function in asthma and/or chronic obstructive pulmonary disease in a real-life setting: the NOVEL observational longiTudinal studY.真实环境中哮喘和/或慢性阻塞性肺疾病患者的症状与肺功能的关系:NOVEL 观察性纵向研究。
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241254212. doi: 10.1177/17534666241254212.
3
Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.一秒用力呼气容积与用力肺活量的支气管扩张剂反应、慢性阻塞性肺疾病加重和死亡率的关系。
Ann Am Thorac Soc. 2019 Jul;16(7):826-835. doi: 10.1513/AnnalsATS.201809-601OC.
4
Peak expiratory flow rate as a surrogate for forced expiratory volume in 1 second in COPD severity classification in Thailand.在泰国慢性阻塞性肺疾病严重程度分级中,呼气峰值流速作为一秒用力呼气量的替代指标。
Int J Chron Obstruct Pulmon Dis. 2015 Jun 25;10:1213-8. doi: 10.2147/COPD.S85166. eCollection 2015.
5
Extracting lung function measurements to enhance phenotyping of chronic obstructive pulmonary disease (COPD) in an electronic health record using automated tools.利用自动化工具从电子健康记录中提取肺功能测量数据,以增强慢性阻塞性肺疾病(COPD)的表型分析。
PLoS One. 2020 Jan 16;15(1):e0227730. doi: 10.1371/journal.pone.0227730. eCollection 2020.
6
Ratio of FEV/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function.用力肺活量与缓慢肺活量之比<0.7 与肺功能正常的吸烟者阻塞性肺疾病的临床、功能和影像学特征相关。
Chest. 2021 Jul;160(1):94-103. doi: 10.1016/j.chest.2021.01.067. Epub 2021 Feb 1.
7
Can We Use Lung Function Thresholds and Respiratory Symptoms to Identify Pre-Chronic Obstructive Pulmonary Disease? A Prospective, Population-based Cohort Study.能否通过肺功能阈值和呼吸系统症状来识别慢性阻塞性肺疾病前期?一项前瞻性、基于人群的队列研究。
Am J Respir Crit Care Med. 2024 Jun 15;209(12):1431-1440. doi: 10.1164/rccm.202212-2330OC.
8
Lung function, forced expiratory volume in 1 s decline and COPD hospitalisations over 44 years of follow-up.44年随访期间的肺功能、1秒用力呼气容积下降情况及慢性阻塞性肺疾病住院情况。
Eur Respir J. 2016 Mar;47(3):742-50. doi: 10.1183/13993003.01575-2015. Epub 2015 Dec 2.
9
Prognostic Value of the Six-Second Spirometry in Patients with Chronic Obstructive Pulmonary Disease: A Cohort Study.六秒肺活量在慢性阻塞性肺疾病患者中的预后价值:一项队列研究
PLoS One. 2015 Oct 21;10(10):e0140855. doi: 10.1371/journal.pone.0140855. eCollection 2015.
10
Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.患有和未患有慢性阻塞性肺疾病的吸烟者的急性加重期及肺功能丧失
Am J Respir Crit Care Med. 2017 Feb 1;195(3):324-330. doi: 10.1164/rccm.201605-1014OC.

本文引用的文献

1
Annual decline rate in FEV1s in community-dwelling older adults diagnosed with mild to moderate COPD.社区居住的轻中度 COPD 老年患者的 FEV1 年下降率。
NPJ Prim Care Respir Med. 2022 Aug 26;32(1):30. doi: 10.1038/s41533-022-00292-w.
2
Machine Learning Prediction of Progression in Forced Expiratory Volume in 1 Second in the COPDGene® Study.慢性阻塞性肺疾病基因(COPDGene®)研究中一秒用力呼气容积进展的机器学习预测
Chronic Obstr Pulm Dis. 2022 Jul 29;9(3):349-365. doi: 10.15326/jcopdf.2021.0275.
3
Electronic Health Records and Pulmonary Function Data: Developing an Interoperability Roadmap. An Official American Thoracic Society Workshop Report.
电子健康记录与肺功能数据:制定互操作性路线图。美国胸科学会官方研讨会报告。
Ann Am Thorac Soc. 2021 Jan;18(1):1-11. doi: 10.1513/AnnalsATS.202010-1318ST.
4
Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic Review.药物治疗与慢性阻塞性肺疾病患者肺功能下降。系统评价。
Am J Respir Crit Care Med. 2021 Mar 15;203(6):689-698. doi: 10.1164/rccm.202005-1854OC.
5
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.中重度至极重度 COPD 患者两种糖皮质激素剂量三联吸入治疗。
N Engl J Med. 2020 Jul 2;383(1):35-48. doi: 10.1056/NEJMoa1916046. Epub 2020 Jun 24.
6
Association between COPD exacerbations and lung function decline during maintenance therapy.COPD 加重与维持治疗期间肺功能下降的关系。
Thorax. 2020 Sep;75(9):744-753. doi: 10.1136/thoraxjnl-2019-214457. Epub 2020 Jun 12.
7
Lung Function Trajectories Leading to Chronic Obstructive Pulmonary Disease as Predictors of Exacerbations and Mortality.导致慢性阻塞性肺疾病的肺功能轨迹可预测加重和死亡。
Am J Respir Crit Care Med. 2020 Jul 15;202(2):210-218. doi: 10.1164/rccm.201911-2115OC.
8
Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement.肺功能测定标准化 2019 修订版。美国胸科学会和欧洲呼吸学会官方技术声明。
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88. doi: 10.1164/rccm.201908-1590ST.
9
An Individualized Prediction Model for Long-term Lung Function Trajectory and Risk of COPD in the General Population.个体化预测模型用于预测一般人群的长期肺功能轨迹和 COPD 风险。
Chest. 2020 Mar;157(3):547-557. doi: 10.1016/j.chest.2019.09.003. Epub 2019 Sep 19.
10
Rate of normal lung function decline in ageing adults: a systematic review of prospective cohort studies.老年人正常肺功能下降率:前瞻性队列研究的系统评价。
BMJ Open. 2019 Jun 27;9(6):e028150. doi: 10.1136/bmjopen-2018-028150.